Intranasal mupirocin prophylaxis in elective surgery: A review of published studies

Chemotherapy

Volumn 54, Issue 1, 2007, Pages 9-16

  Trautmann, M ^a   Stecher, J ^a   Hemmer, W ^b   Luz, K ^b   Panknin, H T ^c  

^a KLINIKUM STUTTGART   (Germany)

^b SANA KLINIKUM OFFENBACH   (Germany)

^c NONE

Author keywords

Methicillin resistant Staphylococcus aureus; Mupirocin; Staphylococcus aureus; Surgical site infection

Indexed keywords

PLACEBO; PSEUDOMONIC ACID;

ANTIBIOTIC PROPHYLAXIS; CLINICAL TRIAL; COHORT ANALYSIS; DRUG EFFECT; ELECTIVE SURGERY; HUMAN; MEDLINE; MORNING DOSAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; REVIEW; STAPHYLOCOCCUS AUREUS; STERNOTOMY; SURGICAL INFECTION; SURGICAL PATIENT;

ADMINISTRATION, INTRANASAL; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CARRIER STATE; CLINICAL TRIALS AS TOPIC; HUMANS; METHICILLIN RESISTANCE; MUPIROCIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION;

EID: 37349081379     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112312     Document Type: Review

References (33)

1. Giacometti A, Cirioni O, Schimizzi M: Epidemiology and microbiology of surgical wound infections. J Clin Microbiol 2000;38:918-922.
2. Weiss CA 3rd, Statz CL, Dahms RA, et al: Six years of surgical wound infection surveillance at a tertiary care center: review of the microbiologic and epidemiological aspects of 20,007 wounds. Arch Surg 1999;134:1041-1048.
3. Knobben BA, van Horn JR, van der Mei HC, Buscher HJ: Evaluation of measures to decrease intraoperative bacterial contamination in orthopedic implant surgery. J Hosp Infect 2006;62:174-180.
4. Lauwers S, de Smet F: Surgical site infections. Acta Clin Belg 1998;53:303-309.
5. Gaynes RP, Culver DH, Horan TC, et al: Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index. Clin Infect Dis 2001;33(suppl 2):S69-S77.
6. Chattopadhyay R, Zaroukian S, Potvin E: Surgical site infection rates at the Pontiac Health Care Centre, a rural community hospital. Can J Rural Med 2006;11:41-48.
7. Kluytmans J, van Belkum A, Verbrugh H: Nasal carriage of Staphylococcus aureus: epidemiology, mechanisms, and associated risks. Clin Microbiol Rev 1997;10:505-520.
8. Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D: Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol 2000;21:319-323.
9. Ahmed AOA, van Belkum A, Fahal AH, et al: Nasal carriage of Staphylococcus aureus and epidemiology of surgical-site infections in a Sudanese university hospital. J Clin Microbiol 1998;36:3614-3618.
10. Kluytmans JA, Mouton JW, Ijzerman EPF: Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 1995;171:216-219.
11. Wenzel RP, Perl TM: The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect 1995;31:13-24.
12. Casewell MW: The nose: an underestimated source of Staphylococcus aureus causing wound infection. J Hosp Infect 1998;40(suppl B):3-11.
13. Kluytmans JA: Reduction of surgical site infections in major surgery by elimination of nasal carriage of Staphylococcus aureus. J Hosp Infect 1998;40:525-529.
14. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, et al: Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 2002;35:353-358.
15. Suzuki Y, Kamigaki T, Fujino Y, et al: Randomized clinical trial of preoperative intranasal mupirocin to reduce surgical-site infection after digestive surgery. Br J Surg 2003;90:1072-1075.
16. Kluytmans JA, Mouton JW, van den Bergh MF, et al: Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 1996;17:780-785.
17. Gernaat-van der Sluis AJ, Hoogenboom-Verdegaal AM, Edixhoven PJ, et al: Prophylactic mupirocin could reduce orthopedic wound infections:1,044 patients treated with mupirocin compared with 1,260 historical controls. Acta Orthop Scand 1998;69:412-414.
18. Yano M, Doki Y, Inoue M: Preoperative intranasal mupirocin ointment significantly reduces postoperative infection with Staphylococcus aureus in patients undergoing upper gastrointestinal surgery. Surg Today 2000;30:16-21.
19. Cimochowski GE, Harostock MD, Brown R, et al: Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg 2001;71:1572-1578.
20. Usry GH, Johnson L, Weems JJ, Blackhurst D: Process improvement plan for the reduction of sternal surgical site infections among patients undergoing artery bypass graft surgery. Am J Infect Control 2002;30:434-436.
21. Konvalinka A, Errett L, Fong IW: Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery. J Hosp Infect 2006;64:162-168.
22. Wilcox MH, Hall J, Pike H, et al: Use of perioperative mupirocin to prevent methicillinresistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 2003;54:196-201.
23. Nicholson MR, Huesman LA: Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients. Am J Infect Control 2006;34:44-48.
24. Perl TM, Cullen JJC, Wenzel RP: Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002;346:1871-1877.
25. Hamasuna R, Besunoh H, Sueyoshi T, Yakushiji K, Tsukino H, Nagano M, Takehara T, Oseda Y: Bacteria of preoperative urinary tract infections contaminate the surgical fields and develop surgical site infections in urological operations. Int J Urol 2004;11:941-947.
26. Kamat AA, Brancazio L, Gibson M: Wound infections in gynecologic surgery. Infect Dis Obstet Gynecol 2000;8:230-243.
27. Hakansson T, Raahave D, Hansen OH, Pedersen T: Effectiveness of single dose prophylaxis with cefotaxime and metronidazole compared with three doses of cefotaxime alone in elective colorectal surgery. Eur J Surg 1993;159:177-180.
28. Bitkover C, Marcusson E, Ransjö U: Spread of coagulase-negative staphylococci during cardiac operations in a modern operating room. Ann Thorac Surg 2000;69:1110-1115.
29. Lidwell O, Lowbury E, Whyte W, et al: Bacteria isolated from deep joints sepsis after operation for total hip or knee replacement and the sources of the infections with Staphylococcus aureus. J Hosp Infect 1983;4:19-29.
30. Laupland KB, Conly JM: Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis 2003;37:933-938.
31. Fujimara S, Watanabe A: Survey of high- and low-level mupirocin-resistant strains of methicillin-resistant Staphylococcus aureus in 15 Japanese hospitals. Chemotherapy 2003;49:36-38.
32. Lietzau S, Sturmer T, Erb A, et al: Prevalence and determinants of nasal colonization with antibiotic-resistant Staphylococcus aureus among unselected patients attending general practitioners in Germany. Epidemiol Infect 2004;132:655-662.
33. Harbarth S, Sax H, Fankhauser-Rodriguez C, et al: Evaluating the probability of previously unknown carriage of MRSA at hospital admission. Am J Med 2006;119:275.e15-e23.